No association found betweenCYP2D6genotype and early breast cancer events in tamoxifen-treated patients

Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status

(2013) Maria Simonsson et al.   CANCER CAUSES & CONTROL

CYP2D6 and adjuvant tamoxifen: possible differences of outcome in pre- and post-menopausal patients

(2013) Sara Margolin et al.   PHARMACOGENOMICS

The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality

(2012) Danny R. Youlden et al.   Cancer Epidemiology

CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial

(2012) Meredith M. Regan et al.   JNCI-Journal of the National Cancer Institute

Tamoxifen and CYP2D6: A Contradiction of Data

(2012) D. L. Hertz et al.   ONCOLOGIST

Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients

(2011) K B Lundin et al.   BRITISH JOURNAL OF CANCER

CYP2D6 Inhibition and Breast Cancer Recurrence in a Population-Based Study in Denmark

(2011) T. L. Lash et al.   JNCI-Journal of the National Cancer Institute

CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients

(2009) H Jernström et al.   BRITISH JOURNAL OF CANCER

No Increase in Breast Cancer Recurrence with Concurrent Use of Tamoxifen and Some CYP2D6-Inhibiting Medications

(2009) T. P. Ahern et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Interactions Between Tamoxifen and Antidepressants via Cytochrome P450 2D6

(2009) Julie Eve Desmarais et al.   JOURNAL OF CLINICAL PSYCHIATRY

Genotype-guided tamoxifen therapy: time to pause for reflection?

(2009) Timothy L Lash et al.   LANCET ONCOLOGY

Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients

(2009) J M Rae et al.   PHARMACOGENOMICS JOURNAL

Coffee Consumption and CYP1A2*1F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status

(2008) E. Bageman et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION